Novonix (NVNXF) Accounts Payables (2020 - 2025)

Novonix has reported Accounts Payables for 6 years, with the latest figure at $13.3 million in Q4 2025.

• For the quarter ending Q4 2025, Accounts Payables rose 56.27% year-over-year to $13.3 million; the trailing twelve-month figure through Dec 2025 stood at $13.3 million (up 56.27% YoY), and the FY2025 full-year result was $13.3 million, up 56.27% from the prior year.
• Accounts Payables for Q4 2025 stood at $13.3 million, down from $19.5 million in the prior quarter.
• The five-year high for Accounts Payables was $19.5 million in Q2 2025, with the low at $2.4 million in Q4 2021.
• Historically, Accounts Payables has averaged $7.4 million across 5 years, with a median of $6.4 million in 2022.
• The largest YoY upside for Accounts Payables was 194.27% in 2022 against a maximum downside of 17.85% in 2022.
• Novonix's Accounts Payables stood at $2.4 million in 2021, then soared by 194.27% to $7.0 million in 2022, then decreased by 17.17% to $5.8 million in 2023, then surged by 47.99% to $8.5 million in 2024, then surged by 56.27% to $13.3 million in 2025.
• The last three Accounts Payables figures came in at $13.3 million (Q4 2025), $19.5 million (Q2 2025), and $8.5 million (Q4 2024), per Business Quant data.